undamentalytics Newsletter

American Well vs Health Catalyst

Health Catalyst is the larger business, with $311m of revenue in fiscal 2025 against $249m for American Well (1.2 times as much). Health Catalyst grew faster (1.5% against -2.0%). American Well kept more of each dollar of sales as profit: a net margin of -38.4% against -57.2%.

Latest fiscal yearAmerican WellAMWL, 2025Health CatalystHCAT, 2025
Revenue $249m $311m
Revenue growth -2.0% 1.5%
Net income −$95.7m −$178m
Operating margin — -51.7%
Net margin -38.4% -57.2%
Return on equity -35.4% -58.3%
Free cash flow −$66.0m −$237,000
Cash $182m $50.8m
Total debt $0 $161m
Debt to equity — 65.4%
Dividend per share — —
Dividend yield — —
Share buybacks $4,000 $5.0m
Employees 562 1,200
Market value $215m $109m
Price vs our value range — —
Moat score 12 (Weak) 9 (Weak)
Insider trades, 12 months 1 buys, 29 sales 1 buys, 2 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.